These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31131578)

  • 1. Rapid Construction and Immunogenicity Testing of a Novel H5 Virus-Like Particle Prototype Vaccine Against Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus.
    Pénzes Z; Czeglédi A; Nagy Z; Kollár A; Tóth Á; Misák F; Rendes K; Ivók M; Gyimesi R; Lovrecz G; Tretyakova I; El-Attrache J; Palya V; Pushko P
    Avian Dis; 2019 Mar; 63(sp1):203-208. PubMed ID: 31131578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Like Particle Based Vaccine Provides High Level of Protection Against Homologous H5N8 HPAIV Challenge in Mule and Pekin Duck, Including Prevention of Transmission.
    Tatár-Kis T; Dán Á; Felföldi B; Bálint Á; Rónai Z; Dauphin G; Pénzes Z; El-Attrache J; Gardin Y; Palya V
    Avian Dis; 2019 Mar; 63(sp1):193-202. PubMed ID: 31131577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Infection.
    Sultan HA; Arafa AE; Talaat S; Gaballa AA; Kilany WH; Elfeil WK; Shehata AA; Amarin N
    Avian Dis; 2019 Mar; 63(sp1):219-229. PubMed ID: 31713400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
    Niqueux É; Flodrops M; Allée C; Lebras MO; Pierre I; Louboutin K; Guillemoto C; Le Prioux A; Le Bouquin-Leneveu S; Keïta A; Amelot M; Martenot C; Massin P; Cherbonnel-Pansart M; Briand FX; Schmitz A; Cazaban C; Dauphin G; Delquigny T; Lemière S; Watier JM; Mogler M; Tarpey I; Grasland B; Eterradossi N
    Vaccine; 2023 Jan; 41(1):145-158. PubMed ID: 36411134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA; Awad AM; Sedeik ME
    Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of H5N8 High Pathogenicity Avian Influenza Virus in Chickens and Ducks from South Korea in 2020-2021.
    Park MJ; Cha RM; Kye SJ; Lee YN; Kim NY; Baek YG; Heo GB; Sagong M; Lee KN; Lee YJ; Lee EK
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Yuk SS; Erdene-Ochir TO; Kwon JH; Noh JY; Hong WT; Jeong JH; Jeong S; Gwon GB; Shin JI; Sur JH; Song CS
    Vaccine; 2017 Mar; 35(9):1316-1322. PubMed ID: 28169074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P
    Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.
    Pantin-Jackwood MJ; DeJesus E; Costa-Hurtado M; Smith D; Chrzastek K; Kapczynski DR; Suarez DL
    Avian Dis; 2019 Mar; 63(1):90-96. PubMed ID: 31251524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3.4.4 B).
    Maartens LH; Frizzo da Silva L; Dawson S; Love N; Erasmus BJ
    Avian Pathol; 2023 Jun; 52(3):176-184. PubMed ID: 37079321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering a highly productive vaccine strain in embryonated chicken eggs and mammals from a non-pathogenic clade 2·3·4·4 H5N8 strain.
    An SH; Lee CY; Hong SM; Choi JG; Lee YJ; Jeong JH; Kim JB; Song CS; Kim JH; Kwon HJ
    Vaccine; 2019 Sep; 37(42):6154-6161. PubMed ID: 31495597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential Selection and Contribution of Non-Structural Protein 1 (NS1) to the Efficient Transmission of Panzootic Avian Influenza H5N8 Virus Clades 2.3.4.4A and B in Chickens and Ducks.
    Blaurock C; Breithaupt A; Scheibner D; Bagato O; Karger A; Mettenleiter TC; Abdelwhab EM
    J Virol; 2021 Aug; 95(18):e0044521. PubMed ID: 34160261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental infection of highly pathogenic avian influenza viruses, Clade 2.3.4.4 H5N6 and H5N8, in Mandarin ducks from South Korea.
    Son K; Kim YK; Oem JK; Jheong WH; Sleeman JM; Jeong J
    Transbound Emerg Dis; 2018 Jun; 65(3):899-903. PubMed ID: 29266850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.